Literature DB >> 24307138

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

A Matilla-Dueñas1, T Ashizawa, A Brice, S Magri, K N McFarland, M Pandolfo, S M Pulst, O Riess, D C Rubinsztein, J Schmidt, T Schmidt, D R Scoles, G Stevanin, F Taroni, B R Underwood, I Sánchez.   

Abstract

Intensive scientific research devoted in the recent years to understand the molecular mechanisms or neurodegeneration in spinocerebellar ataxias (SCAs) are identifying new pathways and targets providing new insights and a better understanding of the molecular pathogenesis in these diseases. In this consensus manuscript, the authors discuss their current views on the identified molecular processes causing or modulating the neurodegenerative phenotype in spinocerebellar ataxias with the common opinion of translating the new knowledge acquired into candidate targets for therapy. The following topics are discussed: transcription dysregulation, protein aggregation, autophagy, ion channels, the role of mitochondria, RNA toxicity, modulators of neurodegeneration and current therapeutic approaches. Overall point of consensus includes the common vision of neurodegeneration in SCAs as a multifactorial, progressive and reversible process, at least in early stages. Specific points of consensus include the role of the dysregulation of protein folding, transcription, bioenergetics, calcium handling and eventual cell death with apoptotic features of neurons during SCA disease progression. Unresolved questions include how the dysregulation of these pathways triggers the onset of symptoms and mediates disease progression since this understanding may allow effective treatments of SCAs within the window of reversibility to prevent early neuronal damage. Common opinions also include the need for clinical detection of early neuronal dysfunction, for more basic research to decipher the early neurodegenerative process in SCAs in order to give rise to new concepts for treatment strategies and for the translation of the results to preclinical studies and, thereafter, in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24307138      PMCID: PMC3943639          DOI: 10.1007/s12311-013-0539-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  414 in total

1.  Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.

Authors:  K A Sieradzan; A O Mechan; L Jones; E E Wanker; N Nukina; D M Mann
Journal:  Exp Neurol       Date:  1999-03       Impact factor: 5.330

2.  The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2.

Authors:  Linda Hallen; Holger Klein; Carola Stoschek; Silke Wehrmeyer; Ute Nonhoff; Markus Ralser; Jeannine Wilde; Christina Röhr; Michal R Schweiger; Kurt Zatloukal; Martin Vingron; Hans Lehrach; Zoltán Konthur; Sylvia Krobitsch
Journal:  Hum Mol Genet       Date:  2010-10-06       Impact factor: 6.150

3.  Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.

Authors:  Yi Chun Chen; Jennifer R Gatchel; Rebecca W Lewis; Chai-An Mao; Patrick A Grant; Huda Y Zoghbi; Sharon Y R Dent
Journal:  Hum Mol Genet       Date:  2011-10-14       Impact factor: 6.150

4.  Introducing the acetylome.

Authors:  Karen T Smith; Jerry L Workman
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

Review 5.  Partners in crime: bidirectional transcription in unstable microsatellite disease.

Authors:  Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Hum Mol Genet       Date:  2010-04-04       Impact factor: 6.150

6.  A morphologically conserved nonapoptotic program promotes linker cell death in Caenorhabditis elegans.

Authors:  Mary C Abraham; Yun Lu; Shai Shaham
Journal:  Dev Cell       Date:  2007-01       Impact factor: 12.270

7.  Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.

Authors:  Bernd O Evert; Julieta Araujo; Ana M Vieira-Saecker; Rob A I de Vos; Sigrid Harendza; Thomas Klockgether; Ullrich Wüllner
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

8.  Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia.

Authors:  Vikram G Shakkottai; Chin-hua Chou; Salvatore Oddo; Claudia A Sailer; Hans-Günther Knaus; George A Gutman; Michael E Barish; Frank M LaFerla; K George Chandy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

9.  Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.

Authors:  Raquel Sanchez-Varo; Laura Trujillo-Estrada; Elisabeth Sanchez-Mejias; Manuel Torres; David Baglietto-Vargas; Ines Moreno-Gonzalez; Vanessa De Castro; Sebastian Jimenez; Diego Ruano; Marisa Vizuete; Jose Carlos Davila; Jose Manuel Garcia-Verdugo; Antonio Jesus Jimenez; Javier Vitorica; Antonia Gutierrez
Journal:  Acta Neuropathol       Date:  2011-10-22       Impact factor: 17.088

10.  Polyglutamine genes interact to modulate the severity and progression of neurodegeneration in Drosophila.

Authors:  Derek Lessing; Nancy M Bonini
Journal:  PLoS Biol       Date:  2008-02       Impact factor: 8.029

View more
  46 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 2.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

Review 3.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 4.  Dilemma of multiple system atrophy and spinocerebellar ataxias.

Authors:  Ming Li; Qianqian Ma; Xing Zhao; Can Wang; Huijie Wu; Jinyao Li; Wei Yang
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

5.  Gene co-expression network analysis for identifying modules and functionally enriched pathways in SCA2.

Authors:  Lance T Pflieger; Warunee Dansithong; Sharan Paul; Daniel R Scoles; Karla P Figueroa; Pratap Meera; Thomas S Otis; Julio C Facelli; Stefan M Pulst
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

6.  Paradigm for disease deconvolution in rare neurodegenerative disorders in Indian population: insights from studies in cerebellar ataxias.

Authors:  Renu Kumari; Deepak Kumar; Samir K Brahmachari; Achal K Srivastava; Mohammed Faruq; Mitali Mukerji
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

7.  In Vivo Analysis of the Climbing Fiber-Purkinje Cell Circuit in SCA2-58Q Transgenic Mouse Model.

Authors:  Polina A Egorova; Alexandra V Gavrilova; Ilya B Bezprozvanny
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

8.  Effects of the enlargement of polyglutamine segments on the structure and folding of ataxin-2 and ataxin-3 proteins.

Authors:  Jingran Wen; Daniel R Scoles; Julio C Facelli
Journal:  J Biomol Struct Dyn       Date:  2016-05-20

Review 9.  The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability.

Authors:  Katherine E Hekman; Christopher M Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-18       Impact factor: 10.154

Review 10.  Update on the Treatment of Ataxia: Medication and Emerging Therapies.

Authors:  Susan L Perlman
Journal:  Neurotherapeutics       Date:  2020-10-06       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.